Scientists profiling small non-coding RNAs in postmortem brain tissue from people with schizophrenia and bipolar disorder have identified sweeping molecular disruptions that extend well beyond the ...

Newron Pharmaceuticals’ add-on schizophrenia treatment improved both positive and negative symptoms as well as severity in patients with the disorder during a phase 2/3 study. The Italian biotech is ...

Ongoing research is needed on long-term trends in the incidence of psychotic disorders associated with changes in cannabis policy. HealthDay News — The proportion of incident cases of schizophrenia ...

Welcome to State of Mind, a new section from Slate and Arizona State University dedicated to exploring mental health. Follow us on Twitter. This article was adapted from Schizophrenia: An Unfinished ...